These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23814481)

  • 1. Targeting cathepsin E in pancreatic cancer by a small molecule allows in vivo detection.
    Keliher EJ; Reiner T; Earley S; Klubnick J; Tassa C; Lee AJ; Ramaswamy S; Bardeesy N; Hanahan D; Depinho RA; Castro CM; Weissleder R
    Neoplasia; 2013 Jul; 15(7):684-93. PubMed ID: 23814481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
    Uno K; Azuma T; Nakajima M; Yasuda K; Hayakumo T; Mukai H; Sakai T; Kawai K
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer.
    Pontious C; Kaul S; Hong M; Hart PA; Krishna SG; Lara LF; Conwell DL; Cruz-Monserrate Z
    Pancreatology; 2019 Oct; 19(7):951-956. PubMed ID: 31582345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring pancreatic carcinogenesis by the molecular imaging of cathepsin E in vivo using confocal laser endomicroscopy.
    Li H; Li Y; Cui L; Wang B; Cui W; Li M; Cheng Y
    PLoS One; 2014; 9(9):e106566. PubMed ID: 25184278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.
    Cruz-Monserrate Z; Abd-Elgaliel WR; Grote T; Deng D; Ji B; Arumugam T; Wang H; Tung CH; Logsdon CD
    Gut; 2012 Sep; 61(9):1315-22. PubMed ID: 22068166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of active targeting, enzyme-triggered release and fluorescent dye into gold nanoclusters for endomicroscopy-guided photothermal/photodynamic therapy to pancreatic ductal adenocarcinoma.
    Li H; Wang P; Deng Y; Zeng M; Tang Y; Zhu WH; Cheng Y
    Biomaterials; 2017 Sep; 139():30-38. PubMed ID: 28582716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors.
    O'Donoghue AJ; Ivry SL; Chaudhury C; Hostetter DR; Hanahan D; Craik CS
    Biol Chem; 2016 Sep; 397(9):871-81. PubMed ID: 27149201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cancer-associated Cathepsin E as a drug activator.
    Abd-Elgaliel WR; Cruz-Monserrate Z; Wang H; Logsdon CD; Tung CH
    J Control Release; 2013 May; 167(3):221-7. PubMed ID: 23422726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical pharmacodynamic evaluation of a new Src/FOSL1 inhibitor, LY-1816, in pancreatic ductal adenocarcinoma.
    Yang W; Meng L; Chen K; Tian C; Peng B; Zhong L; Zhang C; Yang X; Zou J; Yang S; Li L
    Cancer Sci; 2019 Apr; 110(4):1408-1419. PubMed ID: 30618127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cathepsin E in pancreas: a possible tumor marker for pancreas, a preliminary report.
    Azuma T; Hirai M; Ito S; Yamamoto K; Taggart RT; Matsuba T; Yasukawa K; Uno K; Hayakumo T; Nakajima M
    Int J Cancer; 1996 Aug; 67(4):492-7. PubMed ID: 8759606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging.
    Eser S; Messer M; Eser P; von Werder A; Seidler B; Bajbouj M; Vogelmann R; Meining A; von Burstin J; Algül H; Pagel P; Schnieke AE; Esposito I; Schmid RM; Schneider G; Saur D
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9945-50. PubMed ID: 21628592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.
    Lastraioli E; Perrone G; Sette A; Fiore A; Crociani O; Manoli S; D'Amico M; Masselli M; Iorio J; Callea M; Borzomati D; Nappo G; Bartolozzi F; Santini D; Bencini L; Farsi M; Boni L; Di Costanzo F; Schwab A; Onetti Muda A; Coppola R; Arcangeli A
    Br J Cancer; 2015 Mar; 112(6):1076-87. PubMed ID: 25719829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Preclinical Validation of a Cysteine Knottin Peptide Targeting Integrin αvβ6 for Near-infrared Fluorescent-guided Surgery in Pancreatic Cancer.
    Tummers WS; Kimura RH; Abou-Elkacem L; Beinat C; Vahrmeijer AL; Swijnenburg RJ; Willmann JK; Gambhir SS
    Clin Cancer Res; 2018 Apr; 24(7):1667-1676. PubMed ID: 29298796
    [No Abstract]   [Full Text] [Related]  

  • 16. UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.
    Martinez-Useros J; Georgiev-Hristov T; Fernández-Aceñero MJ; Borrero-Palacios A; Indacochea A; Guerrero S; Li W; Cebrián A; Gómez Del Pulgar T; Puime-Otin A; Del Puerto-Nevado L; Rodríguez-Remírez M; Pérez N; Celdrán A; Gebauer F; Garcia-Foncillas J
    PLoS One; 2017; 12(8):e0182044. PubMed ID: 28763470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Enzyme-Activatable Aggregation-Induced-Emission Probe: Intraoperative Pathological Fluorescent Diagnosis of Pancreatic Cancer via Specific Cathepsin E.
    Zhu Z; Wang Q; Chen X; Wang Q; Yan C; Zhao X; Zhao W; Zhu WH
    Adv Mater; 2022 Jan; 34(3):e2107444. PubMed ID: 34693566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
    Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
    J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
    Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
    Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.